Lisinopril and allergies
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Lisinopril and Allergies: Understanding the Connection
Introduction to Lisinopril and Allergic Reactions
Lisinopril, an angiotensin-converting enzyme (ACE) inhibitor, is commonly prescribed for hypertension and heart failure. However, its use has been associated with certain allergic reactions, particularly angioedema, which can be severe and life-threatening. This article explores the relationship between lisinopril and allergies, focusing on angioedema and its interaction with pollen-food allergy syndrome (PFAS).
Angioedema and ACE Inhibitors
Bradykinin-Mediated Angioedema
Angioedema associated with ACE inhibitors like lisinopril is primarily bradykinin-mediated. Bradykinin is a peptide that causes blood vessels to dilate, leading to swelling. This type of angioedema can occur at any time during the course of therapy and is characterized by a slower onset, longer duration, and lack of response to typical allergy treatments such as antihistamines, corticosteroids, or epinephrine.
Case Studies of Severe PFAS with Lisinopril
Recent case studies have highlighted severe instances of PFAS in patients concurrently using lisinopril. PFAS is an IgE-mediated hypersensitivity reaction that occurs in individuals with birch pollen allergies. It is triggered by the ingestion of certain fruits, nuts, and vegetables that share structural homology with the birch pollen allergen Bet v 1. In these cases, patients experienced severe angioedema and oral symptoms shortly after consuming specific foods.
Patient 1: Apple-Induced Angioedema
A 65-year-old man with a history of hypertension and seasonal allergic rhinoconjunctivitis, who had been taking lisinopril for ten years, experienced two episodes of tongue and lip angioedema after eating apples. The second episode required emergency treatment with epinephrine, corticosteroids, and antihistamines. Laboratory tests confirmed elevated IgE levels to apple and birch pollen. After switching from lisinopril to losartan, the patient had no further episodes of angioedema over three years.
Patient 2: Jackfruit and Cashew Nut-Induced Angioedema
A 45-year-old man with similar medical history developed three episodes of tongue angioedema after consuming jackfruit and cashew nuts. The third episode necessitated treatment with oral prednisone and antihistamines. Elevated birch-specific IgE levels were detected, and after replacing lisinopril with losartan, the patient remained symptom-free for a year.
Mechanism of Interaction Between Lisinopril and PFAS
The interaction between lisinopril and PFAS is complex. While ACE inhibitor-related angioedema is typically bradykinin-mediated, the rapid onset of symptoms in these cases suggests an IgE-mediated reaction. The presence of ACE inhibitors may exacerbate the severity of PFAS by potentiating the release of histamine from mast cells, leading to more severe clinical symptoms.
Conclusion
Lisinopril, while effective for managing hypertension, can pose significant risks for patients with PFAS, leading to severe angioedema. The cases discussed illustrate the importance of recognizing the potential for severe allergic reactions in patients using ACE inhibitors. Switching to alternative medications like losartan can mitigate these risks and prevent further episodes of angioedema. Understanding the underlying mechanisms can help healthcare providers make informed decisions to ensure patient safety.
Sources and full results
Most relevant research papers on this topic